| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702818 | Urologic Oncology: Seminars and Original Investigations | 2016 | 5 Pages |
Abstract
The proportion of patients undergoing RPLND for NSGCT varies significantly by the type of cancer center and is used most often in academic cancer centers. Utilization of RPLND decreased for stage I NSGCT and increased for stage III NSGCTs during the study period.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Cory M. M.D., Brian M.D., Claudio M.D., Claire M.D., Craig R. M.D., Christopher R. M.D., Siamak M.D.,